Pfizer, the world’s largest drug maker, introduced Bextra in
the United States in 2001, two years after Vioxx hit the market.
Both are COX-2 inhibitor drugs, however, Bextra remains on the
market, used largely by arthritis sufferers.
On Nov. 9, 2004, a study found that patients who took Bextra
were more than twice as likely to suffer heart attacks or stroke.
The study included 5,930 patients, some taking Bextra and some
given a placebo. Pfizer is denying problems with Bextra for
arthritis patients, saying that the only patients who experienced
heart problems were those at very high risk for heart disease.
If you or someone you love has been taking Bextra, you
should consider contacting an experienced Bextra Lawyer now.
Many Bextra lawyers will give you a free case evaluation.
Allsourceinfo provides you with information on the nations
leading law firms with the ability to litigate Bextra lawsuits
Categories:
